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■ IN BRIEF “Quality Improvement Success Stories” are published by the
American Diabetes Association in collaboration with the American College of
Physicians, Inc., and the National Diabetes Education Program. This series is
intended to highlight best practices and strategies from programs and clinics
that have successfully improved the quality of care for people with diabetes or
related conditions. Each article in the series is reviewed and follows a standard
format developed by the editors of Clinical Diabetes. The following article
describes a successful effort to ensure that patients who are at risk for severe
hypoglycemic events have a viable glucagon emergency plan in place.
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The Diabetes Center of Excellence
(DCOE) is a U.S. Air Force diabetes
specialty clinic located at Joint Base
San Antonio, in Lackland, Tex. Its
patients are Department of Defense
(DoD) beneficiaries, including individuals who are on active duty or
retired and their dependents. The
DCOE embraces a multidisciplinary
approach in which several individuals
interact with patients at each encounter (1).
Describe the specific quality
gap addressed through the
initiative.

Our team chose to assess whether our
patients who are at risk for severe hypoglycemic events had an emergency
plan in place consisting of a current
prescription for glucagon, availability
of the glucagon, and someone trained
to administer it if the need arose.
How did you identify this
quality gap? In other words,
where did you get your
baseline data?

The patients targeted were all patients
with type 1 diabetes using either an

insulin pump or multiple daily injection insulin therapy or patients with
type 2 diabetes using insulin pumps.
Patients were identified each day before their scheduled clinic appointments and were provided with a short
questionnaire by licensed vocational
nurses (LVNs) during the screening
process. This form was then given to
the providers for review. If needed,
the provider wrote a glucagon prescription and gave patients verbal and
written instructions on its use.
The questionnaire included the
following questions:
• Do you have glucagon in your
home? Yes or No
• Is it expired? Yes, No, or Don’t
Know
• Have you had a hypoglycemic
event that required assistance?
Yes or No
• Who was taught to use glucagon?
You, Family Member, Other, No
One
Initial data were collected for 3
months in 2013. The providers were
required to complete the bottom of
the questionnaire answering the following questions:
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■ FIGURE 1. Four steps in tracking glucagon prescriptions using the DCOE’s EMR NoteWriter dashboard.

• Did you review this form?
• Did you order glucagon?

2015. An intervention was put in
place to sustain initial gains.

This process was repeated in 2015
for 7 months to determine whether
the improvements made as a result of
the project had been sustained. The
same target population was used.

Describe your core QI team.
Who served as project leader,
and why was this person
selected? Who else served on
the team?

Summarize the initial data
for your practice (before the
improvement initiative).

Data were collected on 218 patients
during 3 months in 2013. Baseline
data revealed that 162 patients
(74.3%) had glucagon in their home;
however, only 84 of those patients
(52.0%) reported it to be in date (i.e.,
not expired). In addition, 23 patients
(10.5%) reported that no one knew
how to use the glucagon kit. A total
of 111 patients (50.9%) reported that
their family members knew how to
use the kit, and 144 patients (66.1%)
reported knowing how to use the kit
themselves.
What was the timeframe
from initiation of your quality
improvement (QI) initiative to
its completion?

This QI project began in May 2013;
follow-up data were collected in
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One of our certified diabetes educators (CDEs) served as project lead.
Our team included our LVNs, CDEs,
providers (including fellows), and the
research director.
Describe the structural changes
you made to your practice
through this initiative.

An addition to the patient files now
tracks all patients identified as using
an intensive insulin regimen, which
places them at risk for severe hypoglycemia. A note in the electronic
medical record (EMR) prompts staff
(LVNs, CDEs, and providers) to address the need for initiating or renewing glucagon prescriptions, generating or updating the emergency plan,
and educating the patient’s friends or
family members on how to administer glucagon in the event of a severe
hypoglycemic reaction (Figure 1). If
a patient’s glucagon was dispensed
more than 1 year ago, the pink box

appears on the dashboard to remind
the provider to prescribe a new glucagon kit. The provider checks the box
when the glucagon is ordered, which
automatically updates the “Glucagon
Dispensed” date in the record.
Additionally, a patient handout
was developed to facilitate training
and for patients’ home reference. This
handout is distributed by providers
and CDEs to patients new to insulin
and to those found to need education
about severe hypoglycemic events.
Glucagon training kits were
obtained from both Eli Lilly and
Company and Novo Nordisk for
training patients in the clinic. We
also share a free phone app called
“Glucagon,” which was created by
Eli Lilly and Company and provides
virtual training on how to administer
glucagon and a reminder system to
alert patients about an approaching
expiration date on their glucagon kit.
Detailed information about this
QI project has been previously published (2).
Describe the most important
changes you made to your
process of care delivery.

Through our EMR system’s NoteWriter
dashboard, providers receive an alert
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concerning a patient’s high risk for severe hypoglycemic events and another
alert if more than 1 year has passed
since a patient was last prescribed glucagon (Figure 1).
A patient handout provides
clear information on the need for
and proper use of a glucagon kit.
Typically, CDEs educate patients
who are at risk for severe hypoglycemic events at a clinic visit using
the handout, which the patient then
takes home for reference. In addition,
CDEs introduce the Eli Lilly and
Company Glucagon app as a potential resource for patients.

• The percentage of patients reporting that family members are
trained to administer glucagon
increased significantly from 50.8%
(111 patients) in 2013 to 79.7%
(159 patients) in 2015.
• The percentage of patients reporting that they were educated in
glucagon administration also significantly increased from 66.2%
(144 patients) to 83.2% (166
patients).

Summarize your final outcome
data (at the end of the
improvement initiative) and
how it compared to your
baseline data.

What lessons did you learn
through your QI process that
you would like to share with
others?

• Only 3 of 200 patients (1.5%) in
2015 reported that no one in their
home knew how to use glucagon,
compared to 23 patients (10.5%)
in 2013.
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What are your next steps?

We continue to engage patients in
conversations about the importance
of having an emergency glucagon kit.

A multidisciplinary approach was crucial to the success of this project. It is
better for a patient to be asked about
glucagon several times than not to be
asked at all. Upon implementation of
the project, we realized we had not

considered some relevant cost-related issues. Within the DoD, medications are predominantly provided by
military treatment facility pharmacies. These pharmacies maintain an
inventory based on past and present
utilization and budget accordingly.
We neglected to inform our pharmacy about our project, and as a result,
the supply of glucagon was quickly
depleted, which brought about an
unexpected increase in costs to the
facility. Clear communication before
implementing the program could
have avoided this issue.
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